- Home
- GOOD vs CSTL Comparison
GOOD vs CSTL Comparison
Compare GOOD & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOOD
- CSTL
- Stock Information
- Founded
- GOOD 2003
- CSTL 2007
- Country
- GOOD United States
- CSTL United States
- Employees
- GOOD 72
- CSTL N/A
- Industry
- GOOD Real Estate Investment Trusts
- CSTL Medical Specialities
- Sector
- GOOD Real Estate
- CSTL Health Care
- Exchange
- GOOD Nasdaq
- CSTL Nasdaq
- Market Cap
- GOOD 614.5M
- CSTL 568.2M
- IPO Year
- GOOD N/A
- CSTL 2019
- Fundamental
- Price
- GOOD $14.17
- CSTL $21.51
- Analyst Decision
- GOOD Hold
- CSTL Strong Buy
- Analyst Count
- GOOD 1
- CSTL 6
- Target Price
- GOOD $15.00
- CSTL $40.00
- AVG Volume (30 Days)
- GOOD 375.7K
- CSTL 330.2K
- Earning Date
- GOOD 05-07-2025
- CSTL 05-05-2025
- Dividend Yield
- GOOD 8.46%
- CSTL N/A
- EPS Growth
- GOOD N/A
- CSTL N/A
- EPS
- GOOD 0.27
- CSTL 0.62
- Revenue
- GOOD $149,388,000.00
- CSTL $332,069,000.00
- Revenue This Year
- GOOD $3.44
- CSTL N/A
- Revenue Next Year
- GOOD $2.60
- CSTL $3.34
- P/E Ratio
- GOOD $53.20
- CSTL $34.69
- Revenue Growth
- GOOD 1.22
- CSTL 51.09
- 52 Week Low
- GOOD $12.67
- CSTL $16.97
- 52 Week High
- GOOD $17.88
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- GOOD 45.80
- CSTL 56.26
- Support Level
- GOOD $12.67
- CSTL $18.03
- Resistance Level
- GOOD $15.12
- CSTL $20.77
- Average True Range (ATR)
- GOOD 0.53
- CSTL 1.27
- MACD
- GOOD 0.04
- CSTL 0.41
- Stochastic Oscillator
- GOOD 61.22
- CSTL 93.06
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.